{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:57:29Z","timestamp":1787684249150,"version":"build-2784847793"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.xphs.2018.10.066","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T16:52:57Z","timestamp":1542732777000},"page":"1506-1511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Particle Size Distribution Analysis of OTC Aerosol or Powder Drug Products With Potential for Inadvertent Inhalation Exposure to Consumers"],"prefix":"10.1016","volume":"108","author":[{"given":"Xiaofei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Rua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wokovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changning","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Keire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.xphs.2018.10.066_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI0215217","article-title":"Mucus clearance as a primary innate defense mechanism for mammalian airways","volume":"109","author":"Knowles","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.xphs.2018.10.066_bib2","series-title":"Aerosol Technology","author":"Hinds","year":"1999"},{"issue":"2","key":"10.1016\/j.xphs.2018.10.066_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.toxlet.2011.05.1038","article-title":"Special aspects of cosmetic spray safety evaluations: principles on inhalation risk assessment","volume":"205","author":"Rothe","year":"2011","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.xphs.2018.10.066_bib4","first-page":"173","article-title":"Deposition and retention models for internal dosimetry of the human respiratory tract","volume":"12","year":"1966","journal-title":"Health Phys"},{"issue":"3","key":"10.1016\/j.xphs.2018.10.066_bib5","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1208\/s12249-013-9984-7","article-title":"Evaluation of an abbreviated impactor for fine particle fraction (FPF) determination of metered dose inhalers (MDI)","volume":"14","author":"Guo","year":"2013","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.xphs.2018.10.066_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/jamp.2015.1283","article-title":"Valved holding chambers and in\u00a0vitro metered dose inhaler performance: effects of flow rate and inhalation delay","volume":"30","author":"Liu","year":"2017","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.xphs.2018.10.066_bib7","series-title":"Casarett and Doull's Toxicology: The Basic Science of Poisons","article-title":"Toxic responses of the respiratory system","author":"Leikauf","year":"2013"},{"issue":"12","key":"10.1016\/j.xphs.2018.10.066_bib8","doi-asserted-by":"crossref","first-page":"257R","DOI":"10.1021\/ac00108a013","article-title":"Particle size analysis","volume":"67","author":"Barth","year":"1995","journal-title":"Anal Chem"},{"issue":"2","key":"10.1016\/j.xphs.2018.10.066_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11095-006-9146-7","article-title":"Particle size analysis in pharmaceutics: principles, methods and applications","volume":"24","author":"Shekunov","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2018.10.066_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1089\/jam.2006.19.409","article-title":"Laser diffractometry as a technique for the rapid assessment of aerosol particle size from inhalers","volume":"19","author":"Mitchell","year":"2006","journal-title":"J\u00a0Aerosol Med"},{"key":"10.1016\/j.xphs.2018.10.066_bib11","series-title":"Part 1: General Principles","article-title":"ISO13320-1 Particle size analysis\u2014laser diffraction methods","year":"1999"},{"key":"10.1016\/j.xphs.2018.10.066_bib12","series-title":"Part 1: Graphical Representation","article-title":"ISO 9276-1 Representation of results of particle size analysis","year":"1998"},{"issue":"4","key":"10.1016\/j.xphs.2018.10.066_bib13","first-page":"1293","article-title":"USP general chapter <429> light diffraction measurement of particle size","volume":"28","year":"2002","journal-title":"Pharmacopoeial Forum"},{"key":"10.1016\/j.xphs.2018.10.066_bib14","series-title":"ASTM E 799-03 Standard Practice for Determining Data Criteria and Processing for Liquid Drop Size Analysis","year":"2015"},{"issue":"1","key":"10.1016\/j.xphs.2018.10.066_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1743-8977-10-12","article-title":"Thoracic and respirable particle definitions for human health risk assessment","volume":"10","author":"Brown","year":"2013","journal-title":"Part Fibre Toxicol"},{"issue":"Suppl 1","key":"10.1016\/j.xphs.2018.10.066_bib16","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1089\/jam.1997.10.Suppl_1.S-3","article-title":"Performance characteristics of pressurized metered dose inhalers in\u00a0vitro","volume":"10","author":"Byron","year":"1997","journal-title":"J\u00a0Aerosol Med"},{"issue":"3","key":"10.1016\/j.xphs.2018.10.066_bib17","first-page":"A20","article-title":"Understanding the importance and effects of shaking on pMDI performance","volume":"29","author":"Newcomb","year":"2016","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.xphs.2018.10.066_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5649\/jjphcs.41.50","article-title":"Effect of shaking on the emitted dose of reservoir dry powder inhaler","volume":"41","author":"Yoshida","year":"2015","journal-title":"J\u00a0Pharm Health Care Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918307305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918307305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T22:36:43Z","timestamp":1552430203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354918307305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0022354918307305"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2018.10.066","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Particle Size Distribution Analysis of OTC Aerosol or Powder Drug Products With Potential for Inadvertent Inhalation Exposure to Consumers","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2018.10.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}